Mendelian randomization (MR) is a statistical method that uses genetic variants as instrumental variables to infer causal relationships between an exposure (e.g., Gut Microbiome composition) and an outcome (e.g., disease).

Because genetic variants are randomly allocated at conception ("nature's randomized trial"), MR can distinguish causation from correlation in observational data—a critical capability for microbiome research, where most evidence is cross-sectional and confounded.

In the WikiBiome vault, MR studies provide the strongest available evidence for causal direction: does Dysbiosis cause disease, or does disease cause dysbiosis? The answer is often "both" (bidirectional MR), which has profound implications for intervention timing and strategy.

Evidence map7 cited passagesInspect provenance +
01
Microbiome → Disease (Forward MR)

| Condition | Causal Taxa | Direction | Effect | Source | |-----------|------------|-----------|--------|--------| | schizophrenia | Clostridia, Betaproteobacteria | Risk | Causal drivers of SCZ | | | type 1 diabetes | Bacteroidetes | Risk | OR=1.24 | | | type 1 diabetes | Eubacterium eligens | Protective | OR=0.64 | | | type 1 diabetes | bifidobacterium | R

02
Disease → Microbiome (Reverse MR)

| Condition | Effect on Microbiome | Source | |-----------|---------------------|--------| | schizophrenia | Akkermansia enrichment is a consequence, not cause | | | gerd | GERD causally depletes 13 taxa → bidirectional vicious cycle | | | Hypertension | Depletes alistipes, phascolarctobacterium, roseburia | MR studies in vault |

03
Metal → Disease (MR)

| Exposure | Condition | Effect | Source | |----------|-----------|--------|--------| | copper | fibromyalgia | Causal risk | OR=1.095 | | | iron | fibromyalgia | Causal protection | OR=0.440 | |

04
Null Results (Equally Important)

multiple sclerosis: No replicable causal single-taxon signal despite many observational associations. MR's discriminating power is demonstrated by what it doesn't find.

05
The Bifidobacterium Paradox

bifidobacterium appears protective in observational studies and is widely used as a probiotic. MR reveals it causally increases risk for T1D (OR=1.605) and celiac disease (OR=1.401). This does not invalidate probiotic use but demands strain-level and context-specific evaluation rather than blanket recommendations.

06
Bidirectional Vicious Cycles

GERD depletes protective taxa, and those taxa causally protect against GERD—a self-reinforcing cycle that explains disease chronicity. This pattern likely applies to other chronic conditions.

07
Distinguishing Cause from Consequence

The most valuable MR contribution: Akkermansia enrichment in schizophrenia is a disease consequence, not a driver. This kind of directional clarity prevents misguided therapeutic targeting.

Contents1. Method2. Key Causal Findings Across Conditions3. Paradigm-Shifting Insights4. Relevance to WikiBiome5. Cross-References

Method#

Core Design: Two-Sample MR#

Nearly all microbiome MR studies in the vault use two-sample bidirectional MR:

  1. Exposure GWAS: Genetic variants (SNPs) associated with gut microbiome composition, primarily from the MiBioGen consortium (n=18,340; 211 taxa; 16S rRNA; multi-ethnic but predominantly European).
  2. Outcome GWAS: Disease-specific GWAS from large biobanks (UK Biobank, FinnGen, etc.).
  3. Instrumental variable analysis: SNPs associated with microbiome features serve as instruments to test whether those features causally affect disease risk.
  4. Bidirectional analysis: The reverse direction (disease→microbiome) is tested separately.

Statistical Methods#

  • IVW (inverse-variance weighted): Primary analysis
  • MR-Egger: Detects and corrects for directional pleiotropy
  • Weighted median: Robust when up to 50% of instruments are invalid
  • MR-PRESSO: Outlier detection and correction
  • Cochran's Q: Heterogeneity assessment

Limitations#

MiBioGen resolution: 16S rRNA gene, genus-level maximum. Species-level and functional (shotgun) GWAS are not yet available at comparable scale. Population ancestry: Predominantly European; generalizability to other populations uncertain.

Weak instruments: Microbiome GWAS effect sizes are small; weak instrument bias may inflate or attenuate causal estimates.

Horizontal pleiotropy: SNPs may affect disease through pathways other than the microbiome. Static snapshot: MR captures genetic predisposition to microbiome composition, not the dynamic, diet-responsive community.

Key Causal Findings Across Conditions#

Microbiome → Disease (Forward MR)#

ConditionCausal TaxaDirectionEffectSource
SchizophreniaClostridia, BetaproteobacteriaRiskCausal drivers of SCZ[1]Zhou 2024 — Gut Microbiome and Schizophrenia: Insights from Two-Sample Mendelian RandomizationKeer Zhou, Ancha Baranova, Hongbao Cao et al. · 2024Open reference 1 ↓
Type 1 DiabetesBacteroidetesRiskOR=1.24[2]Luo 2023 — Gut microbiota and type 1 diabetes: a two-sample bidirectional Mendelian randomization studyLuo M, Sun M, Wang T et al. · 2023Open reference 2 ↓
Type 1 DiabetesEubacterium eligensProtectiveOR=0.64[3]Xu 2022 — Causal relationship between gut microbiota and autoimmune diseases (SLE, RA, IBD, MS, T1D, CeD): two-sample Mendelian randomizationQian Xu, Jing-Jing Ni, Bai-Xue Han et al. · 2022Open reference 3 ↓
Type 1 DiabetesBifidobacteriumRiskOR=1.605[3]Xu 2022 — Causal relationship between gut microbiota and autoimmune diseases (SLE, RA, IBD, MS, T1D, CeD): two-sample Mendelian randomizationQian Xu, Jing-Jing Ni, Bai-Xue Han et al. · 2022Open reference 3 ↓
Gastroesophageal Reflux Disease (GERD)Actinobacteria (Actinomycetota), LachnospiraceaeProtectiveOR=0.93[4]Wang K 2024 — Causal Gut Microbiota-GERD Associations via Bidirectional Mendelian RandomizationKui Wang, Suijian Wang, Yuhua Chen et al. · 2024Open reference 4 ↓
[[cardiovascular-diseasecoronary-artery-disease]]OdoribacterRiskOR=1.206[5]Association of the Gut Microbiota with Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization StudyDan Wang, Xiaoyan Chen, Zhen Li et al. · 2023Open reference 5 ↓
Graves' DiseaseIntestinibacterRiskOR=1.777[6]Zheng 2025 — Gut-thyroid axis causality with AITD: bidirectional Mendelian randomizationTing Zheng, Xin Li, Hongyu Xiang · 2025Open reference 6 ↓
Hashimoto's ThyroiditisAkkermansia muciniphilaProtectiveOR=0.71[6]Zheng 2025 — Gut-thyroid axis causality with AITD: bidirectional Mendelian randomizationTing Zheng, Xin Li, Hongyu Xiang · 2025Open reference 6 ↓
Colorectal CancerLachnospiraRiskOR=4.43MR studies in vault
Celiac DiseaseBifidobacteriumRiskOR=1.401[3]Xu 2022 — Causal relationship between gut microbiota and autoimmune diseases (SLE, RA, IBD, MS, T1D, CeD): two-sample Mendelian randomizationQian Xu, Jing-Jing Ni, Bai-Xue Han et al. · 2022Open reference 3 ↓

Disease → Microbiome (Reverse MR)#

ConditionEffect on MicrobiomeSource
SchizophreniaAkkermansia enrichment is a consequence, not cause[1]Zhou 2024 — Gut Microbiome and Schizophrenia: Insights from Two-Sample Mendelian RandomizationKeer Zhou, Ancha Baranova, Hongbao Cao et al. · 2024Open reference 1 ↓
Gastroesophageal Reflux Disease (GERD)GERD causally depletes 13 taxa → bidirectional vicious cycle[4]Wang K 2024 — Causal Gut Microbiota-GERD Associations via Bidirectional Mendelian RandomizationKui Wang, Suijian Wang, Yuhua Chen et al. · 2024Open reference 4 ↓
HypertensionDepletes Alistipes, Phascolarctobacterium, RoseburiaMR studies in vault

Metal → Disease (MR)#

ExposureConditionEffectSource
CopperFibromyalgiaCausal riskOR=1.095[7]Zeng 2025 — Copper, Iron and Trace Elements in Fibromyalgia (Mendelian Randomization)Zeng et al. · 2025Open reference 7 ↓
IronFibromyalgiaCausal protectionOR=0.440[7]Zeng 2025 — Copper, Iron and Trace Elements in Fibromyalgia (Mendelian Randomization)Zeng et al. · 2025Open reference 7 ↓

Null Results (Equally Important)#

  • Multiple Sclerosis: No replicable causal single-taxon signal despite many observational associations.[3]Xu 2022 — Causal relationship between gut microbiota and autoimmune diseases (SLE, RA, IBD, MS, T1D, CeD): two-sample Mendelian randomizationQian Xu, Jing-Jing Ni, Bai-Xue Han et al. · 2022Open reference 3 ↓ MR's discriminating power is demonstrated by what it doesn't find.

Paradigm-Shifting Insights#

The Bifidobacterium Paradox#

Bifidobacterium appears protective in observational studies and is widely used as a probiotic. MR reveals it causally increases risk for T1D (OR=1.605) and celiac disease (OR=1.401).[3]Xu 2022 — Causal relationship between gut microbiota and autoimmune diseases (SLE, RA, IBD, MS, T1D, CeD): two-sample Mendelian randomizationQian Xu, Jing-Jing Ni, Bai-Xue Han et al. · 2022Open reference 3 ↓ This does not invalidate probiotic use but demands strain-level and context-specific evaluation rather than blanket recommendations.

Bidirectional Vicious Cycles#

GERD depletes protective taxa, and those taxa causally protect against GERD—a self-reinforcing cycle that explains disease chronicity.[4]Wang K 2024 — Causal Gut Microbiota-GERD Associations via Bidirectional Mendelian RandomizationKui Wang, Suijian Wang, Yuhua Chen et al. · 2024Open reference 4 ↓ This pattern likely applies to other chronic conditions.

Distinguishing Cause from Consequence#

The most valuable MR contribution: Akkermansia enrichment in schizophrenia is a disease consequence, not a driver.[1]Zhou 2024 — Gut Microbiome and Schizophrenia: Insights from Two-Sample Mendelian RandomizationKeer Zhou, Ancha Baranova, Hongbao Cao et al. · 2024Open reference 1 ↓ This kind of directional clarity prevents misguided therapeutic targeting.

Relevance to WikiBiome#

MR studies serve as the causal backbone of WikiBiome's knowledge graph. While observational studies identify associations, MR provides the directional arrows.

For entity pages: MR evidence determines whether a taxon-disease association is causal (drives intervention strategy) or consequential (useful as biomarker only). For signature pages: MR helps distinguish which signature layers are causally upstream vs. reactive downstream changes.

For intervention pages: Only causally implicated taxa are rational therapeutic targets; MR filters signal from noise.

Cross-References#

  • gut microbiome—The exposure most commonly instrumented in microbiome MR
  • Biomarkers—MR distinguishes causal targets from biomarkers
  • Bifidobacterium—The paradox case
  • Akkermansia muciniphila—Consequence, not cause, in schizophrenia
  • Co-Selection—Metal exposure as a confound MR can help untangle
  • Iron—Causally protective in fibromyalgia (MR)
  • Copper—Causally harmful in fibromyalgia (MR)
Generated evidence record

References 14

Numbered by first appearance in the article, then reconciled with its declared source list.

  1. 1

    Keer Zhou, Ancha Baranova, Hongbao Cao et al. (2024). Zhou 2024 — Gut Microbiome and Schizophrenia: Insights from Two-Sample Mendelian Randomization. Schizophrenia (Nature Partner Journal).

  2. 2

    Luo M, Sun M, Wang T et al. (2023). Luo 2023 — Gut microbiota and type 1 diabetes: a two-sample bidirectional Mendelian randomization study. Frontiers in Cellular and Infection Microbiology.

  3. 3

    Qian Xu, Jing-Jing Ni, Bai-Xue Han et al. (2022). Xu 2022 — Causal relationship between gut microbiota and autoimmune diseases (SLE, RA, IBD, MS, T1D, CeD): two-sample Mendelian randomization. Frontiers in Immunology.

  4. 4

    Kui Wang, Suijian Wang, Yuhua Chen et al. (2024). Wang K 2024 — Causal Gut Microbiota-GERD Associations via Bidirectional Mendelian Randomization. Frontiers in Immunology.

  5. 5

    Dan Wang, Xiaoyan Chen, Zhen Li et al. (2023). Association of the Gut Microbiota with Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study. Frontiers in Genetics.

  6. 6

    Ting Zheng, Xin Li, Hongyu Xiang (2025). Zheng 2025 — Gut-thyroid axis causality with AITD: bidirectional Mendelian randomization. Endokrynologia Polska.

  7. 7

    Zeng et al. (2025). Zeng 2025 — Copper, Iron and Trace Elements in Fibromyalgia (Mendelian Randomization). Scientific Reports.

  8. 8

    Ni JJ, Xu Q, Yan SS et al. (2022). Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study. Frontiers in Microbiology.

  9. 9

    Zuming Li, Qinghua Xia, Jieni Feng et al. (2024). Li et al 2024 — The Causal Role of Gut Microbiota in Susceptibility of Long COVID: A Mendelian Randomization Study. Frontiers in Microbiology.

  10. 10

    Gang He, Yu Cao, Honghao Ma et al. (2023). He et al 2023 — Causal Effects Between Gut Microbiome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Two-Sample Mendelian Randomization Study. Frontiers in Microbiology.

  11. 11

    Mike A Nalls, Andrew B Singleton, Haydeh Payami (2021). Nalls 2021 -- Mendelian Randomization of the Gut Microbiome and Parkinson's Disease. npj Parkinson's Disease.

  12. 12

    Youjie Zeng, Si Cao, Heng Yang (2023). Roles of gut microbiome in epilepsy risk: a Mendelian randomization study. Frontiers in Microbiology.

  13. 13

    Yuxuan Zhang, Xinyi Zhang, Delong Chen et al. (2022). Causal Associations between Gut Microbiome and Cardiovascular Disease: A Mendelian Randomization Study. Frontiers in Cardiovascular Medicine.

  14. 14

    Zhichen Jiang, Yiping Mou, Huiju Wang et al. (2023). Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study. BMC Cancer.

Knowledge graph

Article network

Current recordMendelian RandomizationMechanisms
MechanismsGut MicrobiomeReferenced in this mechanisms recordMechanismsDysbiosisReferenced in this mechanisms recordDiseasesSchizophreniaReferenced in this mechanisms recordDiseasesType 1 DiabetesReferenced in this mechanisms recordMicroorganismsBifidobacteriumReferenced in this mechanisms recordDiseasesGastroesophageal Reflux Disease (GERD)Referenced in this mechanisms recordMicroorganismsActinobacteria (Actinomycetota)Mutually connected recordsMicroorganismsLachnospiraceaeReferenced in this mechanisms recordDiseasesCardiovascular DiseaseReferenced in this mechanisms recordMicroorganismsOdoribacterReferenced in this mechanisms recordDiseasesGraves' DiseaseReferenced in this mechanisms recordOtherIntestinibacterReferenced in this mechanisms record
Researcher discussion

Connect the evidence

Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.

0 posts

No discussion yet. Start with a precise question or a source-backed observation.

Transparent record

Activity and accepted changes

Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.

4 events
  1. published revision

    Backfill gut microbiome concept links

    Karen Pendergrass · +2 −2

    Inspect exact Git diff ↗
  2. published revision

    Complete corpus-wide Dysbiosis linking

    Karen Pendergrass · +1 −1

    Inspect exact Git diff ↗
  3. published revision

    massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers

    WikiBiome Deploy Bot · +22 −22

    Inspect exact Git diff ↗
  4. published revision

    pre-overnight checkpoint 2026-04-18

    WikiBiome Deploy Bot · +114 −0

    Inspect exact Git diff ↗
Continue exploring

Every article is a doorway.

Generated from the WikiBiome Markdown vault and reconciled against its source registry.

14 references · 4 backlinks · 7 indexed topics